Association between diffuse myocardial fibrosis by cardiac magnetic resonance contrast-enhanced T₁ mapping and subclinical myocardial dysfunction in diabetic patients: a pilot study
- PMID: 22135399
- DOI: 10.1161/CIRCIMAGING.111.965608
Association between diffuse myocardial fibrosis by cardiac magnetic resonance contrast-enhanced T₁ mapping and subclinical myocardial dysfunction in diabetic patients: a pilot study
Erratum in
- Circ Cardiovasc Imaging. 2012 Mar;5(2):e25
Abstract
Background: Diabetic patients have increased interstitial myocardial fibrosis on histological examination. Magnetic resonance imaging (MRI) T(1) mapping is a previously validated imaging technique that can quantify the burden of global and regional interstitial fibrosis. However, the association between MRI T(1) mapping and subtle left ventricular (LV) dysfunction in diabetic patients is unknown.
Methods and results: Fifty diabetic patients with normal LV ejection fraction (EF) and no underlying coronary artery disease or regional macroscopic scar on MRI delayed enhancement were prospectively recruited. Diabetic patients were compared with 19 healthy controls who were frequency matched in age, sex and body mass index. There were no significant differences in mean LV end-diastolic volume index, end-systolic volume index and LVEF between diabetic patients and healthy controls. Diabetic patients had significantly shorter global contrast-enhanced myocardial T(1) time (425±72 ms vs. 504±34 ms, P<0.001). There was no correlation between global contrast-enhanced myocardial T(1) time and LVEF (r=0.14, P=0.32) in the diabetic patients. However, there was good correlation between global contrast-enhanced myocardial T(1) time and global longitudinal strain (r=-0.73, P<0.001). Global contrast-enhanced myocardial T(1) time was the strongest independent determinant of global longitudinal strain on multivariate analysis (standardized β=-0.626, P<0.001). Similarly, there was good correlation between global contrast-enhanced myocardial T(1) time and septal E' (r=0.54, P<0.001). Global contrast-enhanced myocardial T(1) time was also the strongest independent determinant of septal E' (standardized β=0.432, P<0.001).
Conclusions: A shorter global contrast-enhanced myocardial T(1) time was associated with more impaired longitudinal myocardial systolic and diastolic function in diabetic patients.
Comment in
-
The detection of myocardial fibrosis: an opportunity to reduce cardiovascular risk in patients with diabetes mellitus?Circ Cardiovasc Imaging. 2012 Jan;5(1):9-11. doi: 10.1161/CIRCIMAGING.111.971143. Circ Cardiovasc Imaging. 2012. PMID: 22253334 No abstract available.
Similar articles
-
Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping.J Am Coll Cardiol. 2008 Nov 4;52(19):1574-80. doi: 10.1016/j.jacc.2008.06.049. J Am Coll Cardiol. 2008. PMID: 19007595
-
Cardiac remodelling identified by cardiovascular magnetic resonance in patients with hepatitis C infection and liver disease.Int J Cardiovasc Imaging. 2016 Apr;32(4):629-36. doi: 10.1007/s10554-015-0824-6. Epub 2015 Dec 15. Int J Cardiovasc Imaging. 2016. PMID: 26667447
-
Investigation of global and regional myocardial mechanics with 3-dimensional speckle tracking echocardiography and relations to hypertrophy and fibrosis in hypertrophic cardiomyopathy.Circ Cardiovasc Imaging. 2014 Jan;7(1):11-9. doi: 10.1161/CIRCIMAGING.113.000842. Epub 2013 Nov 25. Circ Cardiovasc Imaging. 2014. PMID: 24275954
-
Diabetic cardiomyopathy: How can cardiac magnetic resonance help?Acta Diabetol. 2020 Sep;57(9):1027-1034. doi: 10.1007/s00592-020-01528-2. Epub 2020 Apr 13. Acta Diabetol. 2020. PMID: 32285200 Review.
-
Assessment of myocardial fibrosis with cardiovascular magnetic resonance.J Am Coll Cardiol. 2011 Feb 22;57(8):891-903. doi: 10.1016/j.jacc.2010.11.013. J Am Coll Cardiol. 2011. PMID: 21329834 Free PMC article. Review.
Cited by
-
Roles of cMyBP-C phosphorylation on cardiac contractile dysfunction in db/db mice.J Mol Cell Cardiol Plus. 2024 Jun;8:100075. doi: 10.1016/j.jmccpl.2024.100075. Epub 2024 Apr 4. J Mol Cell Cardiol Plus. 2024. PMID: 38957358 Free PMC article.
-
Cardiac Imaging in Heart Failure with Comorbidities.Curr Cardiol Rev. 2017;13(1):63-75. doi: 10.2174/1573403x12666160803100928. Curr Cardiol Rev. 2017. PMID: 27492227 Free PMC article. Review.
-
Vascular imaging in diabetes.Curr Atheroscler Rep. 2014 Apr;16(4):399. doi: 10.1007/s11883-014-0399-z. Curr Atheroscler Rep. 2014. PMID: 24493479 Review.
-
Subclinical left ventricular systolic dysfunction and incident stroke in the elderly: long-term findings from Cardiovascular Abnormalities and Brain Lesions.Eur Heart J Cardiovasc Imaging. 2023 Mar 21;24(4):522-531. doi: 10.1093/ehjci/jeac145. Eur Heart J Cardiovasc Imaging. 2023. PMID: 35900282 Free PMC article.
-
The (dys)functional extracellular matrix.Biochim Biophys Acta. 2015 Nov;1853(11 Pt B):3153-64. doi: 10.1016/j.bbamcr.2015.04.015. Epub 2015 Apr 27. Biochim Biophys Acta. 2015. PMID: 25930943 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical